Revenue: The sum of all revenue fields included for a company's operating activities.
Intellia Therapeutics, Inc. (NTLA) had Revenue of $57.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$57.88M |
$-519.02M |
|
-- |
|
$57.88M |
|
$592.14M |
|
$-534.26M |
|
$15.24M |
|
$-519.02M |
|
$-519.02M |
|
$-519.02M |
|
$-519.02M |
|
$-519.02M |
|
$-519.02M |
|
$-534.26M |
|
$-523.98M |
|
98.85M |
|
98.85M |
|
$-5.25 |
|
$-5.25 |
|
| Balance Sheet Financials | |
$639.86M |
|
$27.38M |
|
$551.15M |
|
$1.19B |
|
$110.85M |
|
-- |
|
$208.21M |
|
$319.06M |
|
$871.96M |
|
$871.96M |
|
$871.96M |
|
102.03M |
|
| Cash Flow Statement Financials | |
$-348.88M |
|
$125.57M |
|
$185.75M |
|
$240.35M |
|
$202.79M |
|
$-37.57M |
|
$154.27M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-923.10% |
|
-923.10% |
|
-905.33% |
|
-896.77% |
|
-896.77% |
|
$-354.66M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
6.80 |
|
53.71 |
|
-59.52% |
|
-59.52% |
|
-43.58% |
|
-59.52% |
|
$8.55 |
|
$-3.59 |
|
$-3.53 |
|